Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan
Infection Control & Hospital Epidemiology · 2025
DOI: 10.1017/ice.2024.161 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Kenta Iijima und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease and General Internal Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan. Hauptthemen laut MEDLINE: COVID-19, Cross Infection, COVID-19 Testing, Patient Admission. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To compare the effectiveness of universal admission testing (UAT) and risk-based testing (RBT) in preventing nosocomial coronavirus disease 2019 (COVID-19) after the implementation of strict infection control measures.
Design
Retrospective multicenter cohort study.
Setting
Five community hospitals in Japan. Patients: 14,028 adult patients admitted emergently from June 1, 2022, to January 31, 2023.
Methods
We calculated crude incidence density rates of community-acquired COVID-19 (positive test ≤4 days postadmission), hospital-acquired COVID-19 (positive test ≥8 days postadmission), total postadmission COVID-19 (all cases of positive test postadmission), and primary cases (sporadic and index cases). A generalized estimating equation model was used to adjust for local incidence (new COVID-19 patients per 100,000 population), single-bed room proportion, and admission proportion of patients older than 65 years.
Results
The weekly local incidence in the study areas was less than 1,800 per 100,000 population (1.8%). Two hospitals implemented RBT and 3 implemented UAT. The median admission testing rate was higher in the UAT group than in the RBT group (95% vs 55%; difference 45.2%, 95% CI, 40.3%–48.8%). Crude and adjusted analyses revealed no significant associations between incidence density rates (IRR; >1 indicates higher incidence with UAT) and admission strategies for any of the outcomes: community-acquired cases (adjusted IRR = 1.23; 95% CI, 0.46–3.31), hospital-acquired cases (1.46; 0.80–2.66), total postadmission COVID-19 (1.22; 0.79–1.87), and primary cases (0.81; 0.59–1.12).
Conclusions
Compared with risk-based testing, universal admission testing may have limited additional benefits in preventing nosocomial COVID-19 transmission during a period of low-moderate local incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infectious Disease and General Internal Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
- Department of Infection Control, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
- Division of Infectious Disease, Kobe University Hospital, Kobe, Japan.
ORCID-Profile: Kenta Iijima
Zitieren
APA
Iijima, K., Osako, H., & Iwata, K. (2025). Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.161
Vancouver
Iijima K, Osako H, Iwata K. Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2024.161
BibTeX
@article{Iijima2025,
author = {Iijima, Kenta and Osako, Hitomi and Iwata, Kentaro},
title = {Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
doi = {10.1017/ice.2024.161}
}
EUVIMED